Skip to main content

Low-Dose Antithrombotic Treatment in Coronary Thrombosis of Kawasaki Disease

Pediatric Cardiology volume 36, pages 503–508 (2015)Cite this article

Abstract

To explore effective and convenient rescue therapy options for coronary artery aneurysms (CAA) with thrombosis in Kawasaki disease (KD). A total of 210 patients with KD between the years 2003 and 2013 were retrospectively reviewed in our institute. 144 of these 210 KD developed CAA, and 10 patients with CAA had associated thrombosis. Thrombosis was confirmed by two-dimensional echocardiograms (2-DE). Laboratory values for CAA were analyzed with and without the thrombus group. The characteristics of CAA were monitored by ultrasound. All patients with thrombus received intravenous (IV) antithrombotic therapy, including urokinase, heparin, and oral warfarin. The effectiveness of antithrombotic treatment was evaluated by measuring the ability to dissolve the thrombus. All thrombi in these patients were preceded by a giant CAA and a history of KD. There are no differences in the blood analyses of both CAA with and without thrombus. Moreover, typical KD symptoms and acute myocardial infarction were not found in CAA with thrombosis. The progression of coronary thrombosis in these patients was arrested by antithrombotic and anti-platelet treatment including low-dose urokinase and heparin. Neither clinical features nor laboratory data could reliably predict CAA associated thrombosis. Therapy with IV anti-thrombus and anti-platelet treatment with low-dose warfarin can effectively dissolve thrombi in KD patients.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Bonduel MM (2006) Oral anticoagulation therapy in children. Thromb Res 118:85–94

    Article  CAS  PubMed  Google Scholar 

  2. Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364:533–544

    Article  PubMed  Google Scholar 

  3. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17:1144–1148

    Article  CAS  PubMed  Google Scholar 

  4. Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057–1061

    CAS  PubMed  Google Scholar 

  5. Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145–148

    Article  CAS  PubMed  Google Scholar 

  6. Ebina T, Ishikawa Y, Uchida K, Suzuki S, Imoto K, Okuda J, Tsukahara K, Hibi K, Kosuge M, Sumita S, Mochida Y, Ishikawa T, Uchino K, Umemura S, Kimura K (2009) A case of giant coronary artery aneurysm and literature review. J Cardiol 53:293–300

    Article  PubMed  Google Scholar 

  7. Fukuhara S, Takase E, Fujimoto T, Takami Y, Yamamoto K, Nishida T, Morimoto A (2005) Coronary ectasia resulting in thrombotic coronary occlusion after warfarin interruption: a case report. J Cardiol 46:195–200

    PubMed  Google Scholar 

  8. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T et al (1984) High-dose intravenous gamma globulin for Kawasaki disease. Lancet 2:1055–1058

    Article  CAS  PubMed  Google Scholar 

  9. Gersony WM (1991) Diagnosis and management of Kawasaki disease. JAMA 265:2699–2703

    Article  CAS  PubMed  Google Scholar 

  10. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)—digest version. Circ J 74:1989–2020

  11. Harada M, Akimoto K, Ogawa S, Kato H, Nakamura Y, Hamaoka K, Saji T, Shimizu T, Kato T (2013) National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease. Pediatr Int 55:690–695

    Article  PubMed  Google Scholar 

  12. Horigome H, Sekijima T, Miyamoto T (1997) Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease. Heart 78:517–518

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Johnson PN, Kuhn RJ (2008) Combination thrombolytic and anti-platelet therapies in an infant with incomplete Kawasaki disease and coronary aneurysms. J Pediatr Pharmacol Ther 13:242–250

    PubMed Central  PubMed  Google Scholar 

  14. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385

    Article  CAS  PubMed  Google Scholar 

  15. Kobayashi H, Takazawa K, Matsumoto C, Ooi K, Nagata T, Katou K, Yoshida M, Aiga M, Aizawa A, Takahashi E, Namatame Y, Kinou M, Yamashina A (2006) The role of intravenous coronary thrombolysis for patients with acute myocardial infarction in different treatment strategies. Intern Med 45:709–714

    Article  PubMed  Google Scholar 

  16. Koren G, Lavi S, Rose V, Rowe R (1986) Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 108:388–392

    Article  CAS  PubMed  Google Scholar 

  17. Kuramochi Y, Ohkubo T, Takechi N, Fukumi D, Uchikoba Y, Ogawa S (2000) Hemodynamic factors of thrombus formation in coronary aneurysms associated with Kawasaki disease. Pediatr Int 42:470–475

    Article  CAS  PubMed  Google Scholar 

  18. Monagle P (2003) Thrombosis in pediatric cardiac patients. Semin Thromb Hemost 29:547–555

    Article  PubMed  Google Scholar 

  19. Nakagawa M, Watanabe N, Okuno M, Okamoto N, Fujino H (2000) Effects of intracoronary tissue-type plasminogen activator treatment in Kawasaki disease and acute myocardial infarction. Cardiology 94:52–57

    Article  CAS  PubMed  Google Scholar 

  20. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP et al (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341–347

    Article  CAS  PubMed  Google Scholar 

  21. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633–1639

    Article  CAS  PubMed  Google Scholar 

  22. O’Brien M, Parness IA, Neufeld EJ, Baker AL, Sundel RP, Newburger JW (2000) Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. Pediatrics 105:E64

    Article  PubMed  Google Scholar 

  23. Okura N, Okuda T, Shiotani S, Kohno M, Hayakawa H, Suzuki A, Kawasaki T (2013) Sudden death as a late sequel of Kawasaki disease: postmortem CT demonstration of coronary artery aneurysm. Forensic Sci Int 225:85–88

    Article  PubMed  Google Scholar 

  24. Suzuki A, Kamiya T, Ono Y, Kohata T, Okuno M (1988) Myocardial ischemia in Kawasaki disease: follow-up study by cardiac catheterization and coronary angiography. Pediatr Cardiol 9:1–5

    Article  CAS  PubMed  Google Scholar 

  25. Tatara K, Kusakawa S (1987) Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr 111:705–710

    Article  CAS  PubMed  Google Scholar 

  26. Terai M, Ogata M, Sugimoto K, Nagai Y, Toba T, Tamai K, Aotsuka H, Niwa K, Nakajima H (1985) Coronary arterial thrombi in Kawasaki disease. J Pediatr 106:76–78

    Article  CAS  PubMed  Google Scholar 

  27. Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22:79–85

    Article  PubMed Central  PubMed  Google Scholar 

  28. Wallace CA, French JW, Kahn SJ, Sherry DD (2000) Initial intravenous gamma globulin treatment failure in Kawasaki disease. Pediatrics 105:E78

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Pediatric Department, Union Hospital, Tongji Medical College, Huang zhong University of Science and Technology, Wuhan, People’s Republic of China

    Hua Peng, Zubo Wu, Yalan Liu & Yali Liu

  2. Ultrasound Department, Union Hospital, Tongji Medical College, Huang zhong University of Science and Technology, Wuhan, People’s Republic of China

    Ling Li & Shuangshuang Kong

  3. Tongji Medical College, Huang zhong University of Science and Technology, Wuhan, People’s Republic of China

    Jing Wu

Authors
  1. Hua Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zubo Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yalan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ling Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuangshuang Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jing Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yali Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yali Liu.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Peng, H., Wu, Z., Liu, Y. et al. Low-Dose Antithrombotic Treatment in Coronary Thrombosis of Kawasaki Disease. Pediatr Cardiol 36, 503–508 (2015). https://doi.org/10.1007/s00246-014-1040-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-014-1040-1

Keywords

  • Kawasaki disease
  • Coronary thrombosis
  • Antithrombotic treatment